Congress Must Rein in GPO Kickbacks and Conflicts of Interest
August 25, 2023 — The American Economic Liberties Project today submitted a comment on House Energy and Commerce Committee Chair Cathy McMorris Rodgers’ discussion draft of the Stop Drug Shortages Act.
JetBlue Says JetBlue’s Merger Will Substantially Harm Consumers
August 24, 2023 — Newly released internal documents from JetBlue Airways document JetBlue’s plan to hike fares by up to 40% on Spirit Airlines flights if the proposed merger between the airlines is approved. In response, the American Economic Liberties Project issued the following statement.
DOJ Breaks Up Too Big to Fail Pharma Firm in Response to Lawbreaking
August 21, 2023 — In response to news that the Department of Justice Antitrust Division has fined Teva Pharmaceuticals and Glenmark Pharmaceuticals $255 million and ordered them to divest their generic versions of cholesterol drug pravastatin to resolve criminal charges of price fixing, the American Economic Liberties Project released the following statement.
Economic Liberties Lays Out a Roadmap for Congress and State Legislators to Crack Down on Junk Fees
August 21, 2023 — In support of President Biden’s efforts to eliminate unfair fee and pricing practices across the economy, the American Economic Liberties Project today released model legislation for Congress to comprehensively ban junk fees. Economic Liberties also released a complementary playbook for state lawmakers, that details ways they can engage in the fight against junk fees in their own communities.
FTC Chair Khan, Antitrust AAG Kanter, and Advocates Discuss Draft Merger Guidelines
August 10, 2023 — At an Economic Liberties event today, Federal Trade Commission Chair Lina Khan and the Department of Justice’s Assistant Attorney General for Antitrust Jonathan Kanter detailed how the newly-released draft merger guidelines will better reflect market realities to safeguard competition.